Simone Colgan Dunlap, Partner

Publications and Presentations

12/04/19 – Newsletter

Simone Colgan Dunlap

Massachusetts Drug Discount Provision Set to Expire January 1, 2020Health & Life Sciences AlertSimone Colgan Dunlap, Leah TinneyThe Massachusetts law permitting pharmacies and pharmaceutical manufacturers to offer drug discounts to consumers is set to expire on January 1, 2020. Although legislators have pushed back this law’s expiration date several times, lawmakers are now working against the clock... Read More

04/29/19 – Newsletter Alabama Board of Pharmacy Imposing 3:1 Technician to Pharmacist Ratio on Non-Resident Pharmacies Health & Life Sciences Alert Nicholas H. Meza, Roger N. Morris, Christine Cassetta, Simone Colgan Dunlap

02/08/19 – Newsletter Winter Blues Client Alert Series: Privacy Concerns in the Collection and Use of Biometric Data Data Privacy Alert Meghan O' Connor, Simone Colgan Dunlap, Rachel H. Weiss, Sarah A. Erdmann

09/06/18 – Article "State Health Care Fraud Law: An AHLA 50-State Survey with Summaries and Links" American Health Lawyers Association, Rhode Island Chapter Simone Colgan Dunlap

08/29/18 – Newsletter Massachusetts Passes Emergency Opioid Legislation Health Law Alert Simone Colgan Dunlap, Leah Tinney

06/14/18 – Newsletter Massachusetts’ Court Creates a New Duty for Pharmacies to Notify Prescribers of Prior Authorization Requirements Health Law Alert Roger N. Morris, Simone Colgan Dunlap

04/10/18 – Presentation "Specialty Pharmacy and the Law" McKesson Corporation By Roger Morris, Amy Peterson, Simone Colgan Dunlap and Nick Meza

12/13/17 – Newsletter Trade Group Sues State of California to Block S.B. 17 Drug Pricing Bill Health Law Alert Simone Colgan Dunlap

11/20/17 – Newsletter California Passes Two Drug Pricing Transparency Laws Health Law Alert Simone Colgan Dunlap, Nicholas H. Meza

09/18/17 – Presentation "Legal Issues in Specialty Pharmacy" National Association of Specialty Pharmacy (NASP) Annual Meeting By Roger N. Morris, Amy Cotton Peterson, Simone Colgan Dunlap, co-presenters

06/01/17 – Presentation "Pharmacy 101" McKesson Corporation By Roger Morris, Simone Colgan Dunlap and Nicholas Meza

09/26/16 – Presentation "State Pharmacy Licensure & Compliance" NASP First Annual Specialty Pharmacy Law Conference By Roger N. Morris, Amy Cotton Peterson, Simone Colgan Dunlap, co-presenters

07/21/16 – Presentation "Discounts, & Rewards & Loyalty Programs, Oh My" Quarles & Brady Pharmacy Law Symposium Simone Colgan Dunlap

07/21/16 – Presentation "Specialty Pharmacy" Quarles & Brady Pharmacy Law Symposium By Simone Colgan Dunlap

03/17/16 – Presentation "Paying for Performance: Understanding Key Issues in Risk Sharing Agreements" Q1 Productions: Specialty Pharmaceutical Reimbursement and Market Access Conference By Simone Colgan Dunlap

03/02/16 – Newsletter ​What’s So Special About Specialty Pharmacy? What Hospitals and Health Systems Need to Know About Specialty Pharmacy Integration Health Law Alert Simone Colgan Dunlap

04/03/15 – Article "The Cost of Coupons: Implications of Recent OIG Guidance on Pharmaceutical Manufacturer Copayment Coupons" America Health Lawyers Association Weekly By Simone Colgan Dunlap

02/19/15 – Article "Pharmacy Law—Examination and Board Review: Arizona Chapter" 2015 Textbook, McGraw Hill Education By Simone Colgan Dunlap, Roger N. Morris

12/18/14 – Article "Big Data, Big Risk: Strategies to Mitigate Risks Associated with Data Monetization" InsideCounsel By Simone Colgan Dunlap

09/19/14 – Presentation "Health Care Reform: A Look Back and A Way Forward" Featured panelist for Greater Phoenix Chamber of Commerce seminar By Simone Colgan Dunlap

09/01/14 – Article "Summary of Fraud and Abuse Statutes and Regulations, Rhode Island" American Health Lawyers Association By Simone Colgan Dunlap

08/19/14 – Newsletter The OIG Green Lights Brand Manufacturer's Discount Drug Program Health Law Update Edward D. Rickert, Simone Colgan Dunlap

01/01/09 – Article "Health Law" Annual Survey of Wisconsin Law By Simone Colgan Dunlap

11/01/08 – Article "Federal District Court in Eleventh Circuit Holds that Failure to Allege Actual Submission of a Specific False Claim is Fatal to an Off-Label Use Marketing Qui Tam Suit" American Society for Pharmacy Law: Rx Ipsa Loquitur, vol. 35, p. 2 By Simone Colgan Dunlap